On January 7, 2025, VIS, Inc. filed a Provisional Patent Application (PPA) for a device and procedure for the treatment of myopia with the United States Patent and Trademark Office.
Opti-K™ is a groundbreaking, noninvasive laser-based procedure designed to address vision issues caused by presbyopia, hyperopia, myopia, and age-related macular degeneration (AMD).